SAR-CoV-2 infection, emerging new variants and the role of activation induced cytidine deaminase (AID) in lasting immunity

Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution

(2021) Jeremy Ratcliff et al.   VIROLOGY

Microbubbles versus Extracellular Vesicles as Therapeutic Cargo for Targeting Drug Delivery

(2021) Mujib Ullah et al.   ACS Nano

The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection

(2021) Nikolaos I. Vlachogiannis et al.   CLINICAL IMMUNOLOGY

Combating the progression of novel coronavirus SARS-CoV-2 infectious Disease: Current state and future prospects in molecular diagnostic and drug discovery

(2021) Arbind Kumar et al.   CURRENT MOLECULAR MEDICINE

Confronting the Delta Variant of SARS-CoV-2, Summer 2021

(2021) Carlos del Rio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

(2021) Delphine Planas et al.   NATURE

Delta’s rise is fuelled by rampant spread from people who feel fine

(2021) Smriti Mallapaty   NATURE

How the Delta variant achieves its ultrafast spread

(2021) Sara Reardon   NATURE

Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage

(2021) Nagavalli Pillalamarri et al.   Translational Oncology

Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response

(2021) Mujib Ullah et al.   Oncotarget

COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact

(2021) David A. Swan et al.   Scientific Reports

Artificial intelligence and guidance of medicine in the bubble

(2021) Asma Akbar et al.   Cell and Bioscience

Heat shock protein 20 promotes sirtuin 1-dependent cell proliferation in induced pluripotent stem cells

(2021) Mujib Ullah et al.   World Journal of Stem Cells

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India

(2021) Sarah Cherian et al.   Microorganisms

V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation

(2020) Xiying Chi et al.   IMMUNOLOGY

AID in Antibody Diversification: There and Back Again

(2020) Yuqing Feng et al.   TRENDS IN IMMUNOLOGY

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2

(2020) Salvatore Di Giorgio et al.   Science Advances

Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories

(2020) P. Simmonds   mSphere

The coronavirus is mutating — does it matter?

(2020) Ewen Callaway   NATURE

Footprint of the host restriction factors APOBEC3 on the genome of human viruses

(2020) Florian Poulain et al.   PLoS Pathogens

COVID-19 pandemic: Mechanistic approaches and gender vulnerabilities

(2020) Luqman Khan et al.   SAUDI PHARMACEUTICAL JOURNAL

An emerging role of CD9 in stemness and chemoresistance

(2019) Mujib Ullah et al.   Oncotarget

Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells

(2018) Mauro Gaya et al.   CELL

A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger’s CATalytic Pocket

(2017) Justin J. King et al.   Frontiers in Immunology

Cellular Innate Immunity: An Old Game with New Players

(2016) Georg Gasteiger et al.   Journal of Innate Immunity

The APOBEC Protein Family: United by Structure, Divergent in Function

(2016) Jason D. Salter et al.   TRENDS IN BIOCHEMICAL SCIENCES

APOBEC3 Proteins in Viral Immunity

(2015) Spyridon Stavrou et al.   JOURNAL OF IMMUNOLOGY

An Evolutionary View of the Mechanism for Immune and Genome Diversity

(2012) L. Kato et al.   JOURNAL OF IMMUNOLOGY